|
KCTD5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.775400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.665800E-01 |
| Normal-vs-Stage2 |
6.530200E-01 |
| Normal-vs-Stage3 |
5.903600E-01 |
| Normal-vs-Stage4 |
6.247000E-01 |
| Stage1-vs-Stage2 |
2.273200E-01 |
| Stage1-vs-Stage3 |
9.538400E-02 |
| Stage1-vs-Stage4 |
2.034800E-01 |
| Stage2-vs-Stage3 |
9.756000E-01 |
| Stage2-vs-Stage4 |
9.808600E-01 |
| Stage3-vs-Stage4 |
9.963800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.907200E-01 |
| Normal-vs-AfricanAmerican |
7.841200E-01 |
| Normal-vs-Asian |
6.459900E-02 |
| Caucasian-vs-AfricanAmerican |
6.242600E-01 |
| Caucasian-vs-Asian |
1.208260E-02 |
| AfricanAmerican-vs-Asian |
2.244600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.129200E-01 |
| Normal-vs-Female |
6.036000E-01 |
| Male-vs-Female |
5.348300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.024000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.762800E-01 |
| Normal-vs-Age(61-80Yrs) |
3.432200E-01 |
| Normal-vs-Age(81-100Yrs) |
1.548600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.702400E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.603880E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.900800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.266800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.082210E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.280400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.380000E-01 |
| Classical-VS-Follicular |
3.373600E-01 |
| Classical-VS-Other |
7.233000E-01 |
| Classical-VS-Normal |
5.018000E-01 |
| Tall-VS-Follicular |
8.355600E-01 |
| Tall-VS-Other |
9.335400E-01 |
| Tall-VS-Normal |
9.619200E-01 |
| Follicular-VS-Other |
9.731000E-01 |
| Follicular-VS-Normal |
8.252800E-01 |
| Other-VS-Normal |
9.444200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.345800E-01 |
| Normal-vs-N1 |
7.661800E-01 |
| N0-vs-N1 |
9.949400E-01 |
|
|
